Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?Central Message

Bibliographic Details
Main Authors: Sandeep Sainathan, MD, Tomas A. Salerno, MD
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:JTCVS Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273621003855
_version_ 1818745042822496256
author Sandeep Sainathan, MD
Tomas A. Salerno, MD
author_facet Sandeep Sainathan, MD
Tomas A. Salerno, MD
author_sort Sandeep Sainathan, MD
collection DOAJ
first_indexed 2024-12-18T02:53:55Z
format Article
id doaj.art-d57f0cd3c1fc489c8ec89d0b260fbca9
institution Directory Open Access Journal
issn 2666-2736
language English
last_indexed 2024-12-18T02:53:55Z
publishDate 2021-12-01
publisher Elsevier
record_format Article
series JTCVS Open
spelling doaj.art-d57f0cd3c1fc489c8ec89d0b260fbca92022-12-21T21:23:23ZengElsevierJTCVS Open2666-27362021-12-018121122Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?Central MessageSandeep Sainathan, MD0Tomas A. Salerno, MD1Division of Congenital Heart Surgery, University of Miami Miller School of Medicine, Miami, Fla; Division of Cardiothoracic Surgery, University of Miami Miller School of Medicine, Miami, FlaDivision of Cardiothoracic Surgery, University of Miami Miller School of Medicine, Miami, Fla; Department of Cardiac Surgery Jackson Memorial Hospital, Miami, Fla; Address for reprints: Tomas A. Salerno, MD, University of Miami Miller School of Medicine and Jackson Memorial Hospital, 1611 NW 12th Ave, Miami, FL 33136.http://www.sciencedirect.com/science/article/pii/S2666273621003855
spellingShingle Sandeep Sainathan, MD
Tomas A. Salerno, MD
Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?Central Message
JTCVS Open
title Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?Central Message
title_full Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?Central Message
title_fullStr Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?Central Message
title_full_unstemmed Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?Central Message
title_short Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?Central Message
title_sort commentary optimal left ventricular assist device duration in bridge to transplantation do we have a choice now or is it a moot point central message
url http://www.sciencedirect.com/science/article/pii/S2666273621003855
work_keys_str_mv AT sandeepsainathanmd commentaryoptimalleftventricularassistdevicedurationinbridgetotransplantationdowehaveachoicenoworisitamootpointcentralmessage
AT tomasasalernomd commentaryoptimalleftventricularassistdevicedurationinbridgetotransplantationdowehaveachoicenoworisitamootpointcentralmessage